What does post-trial access refer to?

What does post-trial access refer to?

• A. Mandatory payment for all participants after trial.
• B. Public release of all collected data immediately after study.
• C. Prohibition of any access after trial.
• D. Access to an effective investigational product after study completion, when appropriate.

Answer: (D)

Post-trial access means continuing access to an effective investigational product for participants after the study ends, when it’s appropriate and there are no satisfactory approved alternatives. This reflects an ethical obligation to those who contributed to the trial, especially if the treatment showed benefit and stopping would deprive them of effective care. It’s not about paying all participants, releasing all study data, or prohibiting access after the trial. The specifics can vary by protocol and local regulations, but the main idea is to let eligible participants maintain access to a beneficial investigational product until a proper alternative or approved treatment is available.

Post-trial access means continuing access to an effective investigational product for participants after the study ends, when it’s appropriate and there are no satisfactory approved alternatives. This reflects an ethical obligation to those who contributed to the trial, especially if the treatment showed benefit and stopping would deprive them of effective care. It’s not about paying all participants, releasing all study data, or prohibiting access after the trial. The specifics can vary by protocol and local regulations, but the main idea is to let eligible participants maintain access to a beneficial investigational product until a proper alternative or approved treatment is available.